Tag: EMBR
Trend Seen for Improved Recurrence-Free Survival With Pembrolizumab in Merkel Cell Carcinoma
Recurrence-free survival was numerically higher with adjuvant pembrolizumab, but difference was not significant
Adding Pembrolizumab to Standard Care Ups Event-Free Survival in Head, Neck Cancer
Addition of neoadjuvant and adjuvant pembrolizumab to standard care significantly improves event-free survival
